Check out our most popular compounded medications! Get Started
Our Montelukast Sodium 4.16 mg/3 mL Oral Liquid is a specially crafted medication designed for ease of administration and precise dosing. This oral liquid formulation is ideal for patients who experience difficulty swallowing solid dosage forms, including pediatric and geriatric populations. Montelukast is a leukotriene receptor antagonist that effectively treats and manages asthma, preventing wheezing and shortness of breath. Additionally, it is used to alleviate symptoms of allergic rhinitis, such as sneezing, stuffy nose, and itchy, watery eyes.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Montelukast Sodium 4.16 mg/3 mL Oral Liquid is a specially compounded medication designed for ease of administration and precise dosing. This oral liquid formulation is particularly beneficial for patients who have difficulty swallowing tablets or capsules, such as children and the elderly. Montelukast, the active ingredient, is a leukotriene receptor antagonist that works by blocking substances in the body called leukotrienes. Leukotrienes are involved in the inflammatory process that triggers asthma and allergic rhinitis symptoms. By inhibiting these substances, montelukast helps to prevent wheezing, difficulty breathing, chest tightness, and coughing caused by asthma.
The 4.16 mg/3 mL strength allows for flexible dosing, which can be adjusted according to the specific needs of the patient. This is particularly important in pediatric patients, where dosing often needs to be precise and tailored to the child's weight. The liquid form ensures that the medication can be measured and administered accurately, ensuring therapeutic effectiveness while minimizing the risk of side effects. It is important for prescribers to consider the patient's age, weight, and severity of symptoms when determining the appropriate dose. Additionally, patients or caregivers should be instructed on how to measure and administer the liquid correctly, and to adhere to the prescribed dosing schedule for optimal management of their condition.
For those interested in using Montelukast Sodium 4.16 mg/3 mL Oral Liquid, it is essential to understand that while it can help control the symptoms of asthma and allergic rhinitis, it is not intended for the relief of acute bronchospasm or as a substitute for inhaled or oral corticosteroids. Patients should continue taking other medications as directed by their healthcare provider and should consult their provider if their symptoms do not improve or if they worsen. If you have any questions or require further information about this formulation, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is committed to providing comprehensive support and guidance to both patients and prescribers.
Montelukast Sodium is a leukotriene receptor antagonist that is commonly used to manage symptoms of asthma and to relieve symptoms of seasonal allergies. When considering the use of Montelukast Sodium 4.16 mg/3 mL Oral Liquid, it is important to be aware of potential drug interactions that may affect the efficacy of the medication or increase the risk of adverse effects.
Montelukast may interact with drugs that are metabolized by the cytochrome P450 system, particularly the CYP2C8 and CYP3A4 isoenzymes. Concurrent use with drugs that induce CYP2C8, such as rifampin, could potentially decrease the plasma concentration of montelukast, leading to reduced effectiveness. Conversely, inhibitors of CYP2C8, such as gemfibrozil, may increase the plasma levels of montelukast, potentially increasing the risk of side effects.
Additionally, caution should be exercised when montelukast is co-administered with other medications known to prolong the QT interval, as there is a theoretical risk of additive effects on the QT interval, although montelukast itself is not known to have any significant effects on cardiac conduction. Patients taking medications with a narrow therapeutic index, such as warfarin, should be monitored closely, as montelukast may alter the plasma concentrations of these drugs.
It is also important to consider the potential for drug interactions with over-the-counter (OTC) medications and herbal supplements. Patients should be advised to consult with their healthcare provider before starting any new medications, including OTC drugs and supplements, while taking montelukast.
Montelukast should be used with caution in patients taking aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs), as these medications may also affect leukotriene pathways. Although montelukast is not a substitute for corticosteroids or a rescue inhaler, it is important to maintain any prescribed asthma or allergy treatment regimen unless otherwise directed by a healthcare provider.
Patients with phenylketonuria should be aware that montelukast chewable tablets may contain phenylalanine, which can be harmful in high amounts for those with this condition. However, this is specific to the chewable tablet formulation and may not be relevant for the oral liquid form described here.
As with any medication, the potential for drug interactions with montelukast should be assessed on an individual basis, taking into account all concomitant medications, including prescription drugs, OTC medications, and herbal supplements. Healthcare providers should review the patient's medication regimen to identify any possible interactions and adjust therapy as needed to ensure safe and appropriate use of montelukast.
If you have any questions or require further information regarding drug interactions with Montelukast Sodium 4.16 mg/3 mL Oral Liquid, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support to both patients and prescribers to ensure optimal treatment outcomes.
The Montelukast Sodium 4.16 mg/3 mL Oral Liquid is a specially designed medication that works by targeting the pathways in the body responsible for inflammation and allergic reactions. Montelukast is a leukotriene receptor antagonist, which means it blocks the action of leukotrienes in the body. Leukotrienes are chemicals produced by the body in response to allergens or other triggers and are responsible for symptoms such as swelling, inflammation, and constriction of airways in the lungs.
When a patient takes this oral liquid, the active ingredient, Montelukast Sodium, is absorbed into the bloodstream through the digestive tract. Once absorbed, it selectively binds to the cysteinyl leukotriene receptors in the lungs and bronchial tubes, preventing leukotrienes from causing their usual effects. This action helps to reduce bronchoconstriction (narrowing of the airways), mucus production, and inflammation, leading to relief from symptoms of asthma and allergic rhinitis (such as sneezing, stuffy nose, and itchy, watery eyes).
This formulation is particularly beneficial for patients who have difficulty swallowing pills, such as young children or the elderly, as well as those with conditions that affect their ability to swallow solid dosage forms. Additionally, the oral liquid can be more palatable and easier to administer, which is an important consideration for maintaining patient adherence to a medication regimen.
Montelukast Sodium Oral Liquid is used in the treatment of asthma to prevent asthma attacks and to decrease the number of acute asthma attacks. It is also used before exercise to prevent breathing problems during exercise (bronchospasm). In patients with allergic rhinitis, it alleviates symptoms such as a runny nose, sneezing, and itching. It is important to note that this medication is not intended for the relief of acute bronchospasm or asthma attacks and should not be used as a rescue medication.
For optimal results, the medication should be taken regularly as prescribed by a healthcare provider. It is also important to continue taking the medication as directed even if symptoms improve, as it is meant for long-term control and not just for immediate symptom relief. If you have any questions about how Montelukast Sodium Oral Liquid works or if it is the right medication for your condition, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need to manage your health effectively.
This liquid formulation of Montelukast is used to treat and prevent asthma, relieve symptoms of allergic rhinitis, and prevent exercise-induced bronchoconstriction. It is especially beneficial for patients who have difficulty swallowing pills or for those who require a precise dosage that can be easily adjusted.
Montelukast Sodium Oral Liquid should be stored at room temperature, away from direct light, heat, and moisture. Keep the bottle tightly closed when not in use and out of reach of children and pets to ensure safety.
Yes, the dosage can be adjusted according to the prescribing physician's guidance. The liquid formulation allows for precise dosing, which is particularly useful for pediatric and geriatric patients who may need doses that are not standard in pill form.
Common side effects may include headache, dizziness, abdominal pain, and cough. Serious side effects are rare but can include mood changes, increased bleeding tendency, and allergic reactions. Contact your healthcare provider if you experience any unusual symptoms.
Montelukast may interact with certain medications, so it is important to inform your healthcare provider of all medications you are taking, including over-the-counter drugs and supplements, to prevent potential interactions.
Yes, this liquid formulation is often prescribed for children, as it is easier for them to ingest compared to solid pills. The dosage should be determined by a pediatrician based on the child's weight and age.
The correct dose should be measured using the dosing syringe, cup, or spoon that comes with the medication to ensure accuracy. Household spoons should not be used as they can lead to incorrect dosing.
If a dose is missed, take it as soon as you remember, unless it is almost time for the next dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to catch up.
It is best to take the medication as directed by your healthcare provider. While it can be administered directly, some physicians may allow it to be mixed with a small amount of food or liquid if it helps with ingestion. Check with your healthcare provider for specific instructions.
There are generally no specific dietary restrictions while taking Montelukast Sodium Oral Liquid, but it is important to discuss your diet and potential food-drug interactions with your doctor. Additionally, some patients may be advised to avoid certain foods that trigger their asthma symptoms.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
